Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 2 |
2011 | 1 |
2016 | 2 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Alzheimers Res Ther. 2021 Apr 17;13(1):80. doi: 10.1186/s13195-021-00813-8.
Alzheimers Res Ther. 2021.
PMID: 33865446
Free PMC article.
Clinical Trial.
Erratum: Lai, R.Y.K.; Harrington, C.R.; Wischik, C.M. Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer's Disease. Biomolecules 2016, 6, 19.
Lai RY, Harrington CR, Wischik CM.
Lai RY, et al.
Biomolecules. 2016 Aug 12;6(3):35. doi: 10.3390/biom6030035.
Biomolecules. 2016.
PMID: 27529285
Free PMC article.
Item in Clipboard
Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer's Disease.
Lai RY, Harrington CR, Wischik CM.
Lai RY, et al.
Biomolecules. 2016 Apr 8;6(2):19. doi: 10.3390/biom6020019.
Biomolecules. 2016.
PMID: 27070645
Free PMC article.
Item in Clipboard
Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, Lannfelt L, Bradley H, Rabe M, Koyama A, Reyderman L, Berry DA, Berry S, Gordon R, Kramer LD, Cummings JL.
Swanson CJ, et al. Among authors: lai ryk.
Alzheimers Res Ther. 2022 May 21;14(1):70. doi: 10.1186/s13195-022-00995-9.
Alzheimers Res Ther. 2022.
PMID: 35598024
Free PMC article.
No abstract available.
Item in Clipboard
Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury.
Anand P, Shenoy R, Palmer JE, Baines AJ, Lai RY, Robertson J, Bird N, Ostenfeld T, Chizh BA.
Anand P, et al. Among authors: lai ry.
Eur J Pain. 2011 Nov;15(10):1040-8. doi: 10.1016/j.ejpain.2011.04.005. Epub 2011 May 14.
Eur J Pain. 2011.
PMID: 21576029
Clinical Trial.
Item in Clipboard
Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET.
Ashworth S, Rabiner EA, Gunn RN, Plisson C, Wilson AA, Comley RA, Lai RY, Gee AD, Laruelle M, Cunningham VJ.
Ashworth S, et al. Among authors: lai ry.
J Nucl Med. 2010 Jul;51(7):1021-9. doi: 10.2967/jnumed.109.071753. Epub 2010 Jun 16.
J Nucl Med. 2010.
PMID: 20554726
Free article.
Item in Clipboard
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.
Tzimopoulou S, Cunningham VJ, Nichols TE, Searle G, Bird NP, Mistry P, Dixon IJ, Hallett WA, Whitcher B, Brown AP, Zvartau-Hind M, Lotay N, Lai RY, Castiglia M, Jeter B, Matthews JC, Chen K, Bandy D, Reiman EM, Gold M, Rabiner EA, Matthews PM.
Tzimopoulou S, et al. Among authors: lai ry.
J Alzheimers Dis. 2010;22(4):1241-56. doi: 10.3233/JAD-2010-100939.
J Alzheimers Dis. 2010.
PMID: 20930300
Clinical Trial.
Item in Clipboard
Cite
Cite